Corrigendum to ‘Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus’ [Clin. Chim. Acta 450 (2015) 145–150]

Autor: Kotani, Kazuo, Tashiro, Jun, Yamazaki, Kenya, Nakamura, Yoshitake, Miyazaki, Akira, Bujo, Hideaki, Saito, Yasushi, Kanno, Takashi, Maekawa, Masato
Zdroj: In Clinica Chimica Acta 1 April 2016 455:210-210
Databáze: ScienceDirect